Summary

• Surveillance tailored to this new phase of the epidemic

• More comprehensive virological surveillance: SI-DEP

• A daily contextualized risk analysis: vulnerability map

• Estimation of the effective reproduction number of the virus (R)

• Contact tracing: methodological support, investigation, and monitoring of infection clusters (MONIC Information System)

• Seroprevalence: what proportion of the French population has been exposed to the virus?

• Targeted or tailored surveillance for emerging phenomena

• Prevention is essential in the fight against COVID-19

• Quantitative and qualitative monitoring indicators

• Communication targeting all audiences, including the most vulnerable

• Santé publique France is collaborating with other stakeholders to advance knowledge

• Support in organizing the biological component of INSERM’s EpiCOV and Sapris surveys

• Participation in the “Tobacco Use and COVID” working group of the High Council for Public Health (HCSP)

• National and international scientific collaborations